Pelvic Infection

10/23/2019 - "Conclusion: The antibiotic irrigation with tube drainage, especially the high concentration perfusion is more effective than saline in the treatment of abdominal and pelvic infection effusion. "
04/01/2001 - "Large well-conducted randomised trials with long term outcome measures are now needed to determine the most effective antibiotic combinations and strategy for prevention of post-abortal pelvic infection."
04/15/1982 - "In this study, neither antibiotic regimen provided satisfactory initial treatment for surgically induced soft tissue pelvic infection. "
03/01/2023 - "Intravenous antibiotics were administered for pelvic infection. "
03/01/2023 - "Oral antibiotics were administered for pelvic infection. "

09/01/1995 - "Eligible studies used parenteral clindamycin 600 mg q8h or 900 mg q8h to treat intraabdominal or pelvic infection in at least 1 arm of a study and provided a definition of clinical outcome. "
09/01/1995 - "In pelvic infections, a dosage of clindamycin 600 mg q8h appears to be clinically acceptable for all patients. "
07/01/1990 - "Clindamycin dosage scheduling for acute pelvic infection."
01/01/1984 - "Clindamycin had been used in treatment of severe abdominal and female pelvic infections for over fifteen years. "
01/01/1984 - "Current experience with clindamycin in the treatment of abdominal and female pelvic infections."

05/01/1983 - "In order to evaluate the efficacy of cefoxitin, 25 patients with serious pelvic infections admitted to a community hospital were treated with the drug. "
05/01/1983 - "The study demonstrated that cefoxitin was successful as a single agent in the treatment of serious soft-tissue pelvic infections."
08/01/1979 - "In addition to being an effective single agent for the management of pelvic infections, cefoxitin proved to be safe and well tolerated by patients."
08/01/1979 - "Cefoxitin: single-agent treatment of mixed aerobic-anaerobic pelvic infections."
10/01/1990 - "A review of the literature indicates that cefoxitin is an effective single-agent therapy for community-acquired intra-abdominal infections, pelvic infections, and surgical prophylaxis. "

11/01/2002 - "Comparative in vitro activities of ertapenem against bacterial pathogens from patients with acute pelvic infection."
01/01/2003 - "Ertapenem has a role in the treatment of CAP associated with typical respiratory pathogens and is of particular value in the treatment of polymicrobial infections (such as CIAI, CSSSI, CUTI and acute pelvic infections), especially where Enterobacteriaceae and anaerobic bacteria are involved."
06/01/2004 - "Monotherapy with ertapenem dosed as 1 g once a day has been shown to be highly effective in clinical trials for the treatment of complicated infections of skin and skin structures, complicated intra-abdominal infections, community-acquired pneumonia, acute pelvic infections and complicated urinary tract infections. "
03/01/2010 - "Given this profile, ertapenem has been found to be useful in intra-abdominal infections, acute pelvic infections, complicated skin and skin structure infections, community-acquired pneumonia and complicated urinary tract infections. "
02/01/2007 - "International guidelines recommend the initial empirical use of ertapenem for intra-abdominal infections, skin and skin-structure infections, acute pelvic infections, complicated urinary tract infections and pneumonia (both community-acquired and 'early-onset' nosocomial) in a dose of 1.0 g administered once daily. "

07/01/1987 - "Clindamycin and gentamicin are frequently prescribed by obstetricians and gynecologists (OB-GYN) for various pelvic infections in women. "
07/01/1987 - " The patient was a 43-year old man who was transferred to Massachusetts General Hospital after being treated unsuccessfully at another hospital with gentamicin and carbenicillin for a pelvic infection. "
11/01/1979 - "A comparison of netilmicin and gentamicin in the treatment of pelvic infections."
11/30/1989 - "In this study of pelvic infection, ciprofloxacin demonstrated efficacy comparable with the combination of clindamycin and gentamicin, and is effective against C. "
03/01/1986 - "In the authors' experience, cefoxitin as a single agent was as effective in the treatment of postoperative pelvic infection as the combination of clindamycin and gentamicin."

03/01/1991 - "Prevention of IUD-related pelvic infection: the efficacy of prophylactic doxycycline at IUD insertion."
05/01/1990 - "Preventing IUCD-related pelvic infection: the efficacy of prophylactic doxycycline at insertion."
01/01/1995 - "The purpose of this study was to investigate the efficacy of 200 mg of prophylactic doxycycline in preventing pelvic infection after curettage for spontaneous (incomplete) abortion. "
05/01/1995 - "To determine whether prophylactic doxycycline at suction curettage for incomplete abortion decreases the rate of postoperative pelvic infection. "
01/01/1995 - "Prophylactic doxycycline is not effective in preventing pelvic infection after curettage for spontaneous (incomplete) abortion."

01/01/1994 - "Piperacillin/tazobactam demonstrates favorable penetration in female genital tract tissues and Should be considered a potentially effective agent for female pelvic infections."
06/01/2004 - "The efficacy of ertapenem 1 g once a day for the treatment of polymicrobial complicated intra-abdominal, complicated skin/skin-structure and acute pelvic infections was compared with piperacillin-tazobactam 3.375 g every 6 h in a post hoc analysis of data from three large randomized double-blind trials. "
01/01/2003 - "In this study, ertapenem was as effective as piperacillin-tazobactam for the treatment of acute pelvic infection, was generally well tolerated, and had an overall safety profile similar to that of piperacillin-tazobactam."
01/01/2003 - "Ertapenem once a day versus piperacillin-tazobactam every 6 hours for treatment of acute pelvic infections: a prospective, multicenter, randomized, double-blind study."
01/01/2002 - "Ertapenem versus piperacillin-tazobactam for treatment of mixed anaerobic complicated intra-abdominal, complicated skin and skin structure, and acute pelvic infections."

10/19/1984 - "A single dose of ceftriaxone before surgery was as effective in preventing major pelvic infection and urinary tract infection as were three perioperative doses of cefazolin given over 16 hours. "
01/01/2006 - "The trials showed equivalence to piperacillin/tazobactam or ceftriaxone in (a) abdominal infections, (b) community-acquired pneumonia, (c) acute pelvic infections, (d) skin and skin structure infections and (e) complicated urinary tract infections. "
09/01/2003 - "Trials show equivalence to piperacillin/tazobactam or ceftriaxone in (a) intra-abdominal infections, (b) community-acquired pneumonia, (c) acute pelvic infections, (d) skin and skin structure infections and (e) complicated urinary tract infections. "
01/01/2005 - "It has similar efficacy to comparator antibacterials such as piperacillin/tazobactam in cSSSI (including diabetic foot infection), cIAI and acute pelvic infection and ceftriaxone with or without metronidazole in cIAI, cUTI and CAP. "
05/01/2003 - "The efficacy of ertapenem, 1 g once a day, for treatment of adults with serious infections caused by Enterobacteriaceae was compared with ceftriaxone 1 g once a day [complicated urinary tract infection (CUTI) and community-acquired pneumonia (CAP)] or piperacillin-tazobactam, 3.375 g every 6 h (complicated intra-abdominal, complicated skin/skin structure and acute pelvic infections). "

10/01/2017 - "A practice improvement strategy using a solitary dose of vaginal metronidazole the night before surgery was initiated to determine if it decreased the risk of pelvic infection. "
09/01/1995 - "The prevalence of metronidazole resistance is widespread in the emergent countries (Glupczynski et al, 1990), but it is also appreciable in the West, especially in women, who may have been given metronidazole in the treatment of pelvic infections (Rautelin et al, 1992; Banatvala et al, 1994). "
09/01/1992 - "For the treatment of moderate to severe mixed aerobic/anaerobic pelvic infections, metronidazole should be considered secondarily in patients who have failed other multiple- or single-drug regimens or in patients who are infected. "
10/01/2017 - "Operative risk factors found to be associated with pelvic infection included hospital length of stay, blood loss, and metronidazole use. "
10/01/2017 - "Preoperative Vaginal Metronidazole Decreases the Risk of Pelvic Infections After Radical Robotic Hysterectomy."

02/01/1984 - "All the women with gonorrhoea were treated at least 48 h pre-operatively with ampicillin and probenicid; three of them had symptoms of pelvic infection pre-operatively and one had symptoms postoperatively. "
10/29/1983 - "On the basis of cost ampicillin would seem to be the treatment of choice in uncomplicated acute pelvic infection."
10/01/1976 - " Febrile morbidity was reduced (p less than .001) in the ampicillin group, the incidence of pelvic infection declining from 18% to 3%. "
10/01/1976 - "The use of prophylactic ampicillin caused significant reduction in both postoperative pelvic infection and hospital stay. "
10/01/1976 - "The effect of prophylactic ampicillin on pelvic infection following vaginal hysterectomy."

10/01/2007 - "Early and appropriate therapy has the potential to significantly reduce the long-term complications of PID, and these evidence-based guidelines provide advice on the management of pelvic infection including the use of appropriate antimicrobial regimens."
12/01/1998 - "These newer agents may be used intravenously or orally as once-daily single-agent therapy for surgical prophylaxis, and in place of combination therapy for complex intra-abdominal and pelvic infections."
04/01/1990 - "In order to treat the symptoms of genito-pelvic infection, an early diagnosis and adequate medical therapy are indispensable. "
09/01/1987 - "Therapy for acute polymicrobial pelvic infections is empiric and must include predictable anaerobic coverage. "
08/01/1987 - "Treatment and prevention of female pelvic infection: the quest for single-agent therapy."

01/01/1989 - "Pelvic infections complicated 16.7% of vaginal hysterectomies having no prophylaxis, but only 4.3% after Doxycyclin medication (p less than 0.05). "
01/01/1980 - "[Prevention of urinary and pelvic infections in radical abdominal hysterectomies, vaginal and abdomino-vaginal operations]."
01/01/1985 - "The 100 patients of the prophylaxis group showed a significant reduction (p less than 0.01) of postoperative fever and of pelvic infections after vaginal hysterectomies. "
06/01/1988 - "Antibiotic prophylaxis has been advocated to reduce the risk of postcesarean endometritis and post-vaginal hysterectomy pelvic infection. "
11/01/2009 - "Women with leiomyomas (P<.001), endometriosis (P<.001), or pelvic infections (P<.001) were more likely to have laparoscopic than vaginal hysterectomy. "

05/01/2014 - "Expectant management of clinically stable women with first-trimester miscarriage is safe and effective and avoids the need for surgery and the subsequent risk of anaesthesia in about 81.4 % of cases, and has lower pelvic infection rate than surgical curettage. "
03/01/1997 - "There were three uterine curettages up to 14 days after discharge from hospital for persistent bleeding and two cases of pelvic infection. "
03/01/1975 - "Potentially serious complications were pelvic infection (0.4%), bleeding requiring a repeat curettage (0.3%), and prolonged bleeding (0.7%). "
12/20/2017 - "Conclusion Other diseases of uterus,history of curettage,pelvic infection,intrauterine device,history of cesarean section,and/or multigravida can increase the risk of IUA after hysteroscopic resection of endometrial polyps. "
12/20/2017 - "Logistic regression analysis showed other diseases of uterus(χ2=19.542,P=0.026),history of curettage (χ2=29.614,P=0.000),pelvic infection (χ2=5.627,P=0.002),intrauterine device (χ2=11.342,P=0.08),history of cesarean section(χ2=8.549,P=0.035),and multigravida (χ2=15.493,P=0.000) were the independent risk factors of IUA after hysteroscopic resection of endometrial polyps. "

10/01/2022 - "Mortality, pelvic infection, and ICU length of stay was not different between these cohorts. "
01/01/1982 - "No pelvic infections were observed in either of the groups and hospital stay was the same in both. "
03/15/1974 - " However, this increased blood loss does not cause a higher incidence of pelvic infection or prolonged postoperative hospital stay."
12/01/2016 - "The aim of this study was to evaluate whether an omental flap after pelvic exenteration reduces the incidence of pelvic infection and the length of postoperative hospital stay. "
10/01/2015 - "Secondary outcomes included estimated blood loss, length of stay, pathology, uterine weight, and complications, including blood transfusion, conversion to open, intraoperative organ injury, pelvic infection, readmission, or reoperation. "

01/01/1992 - "CT of pelvic infection after cesarean section."
03/26/1982 - "A severe pelvic infection developed in a 17-year-old primigravida after a cesarean section. "
03/26/1982 - "Severe pelvic infection from Chlamydia trachomatis after cesarean section."
05/01/1980 - "Identification and management of women at high risk for pelvic infection following cesarean section."
02/01/2011 - "Seven patients had a preimplant history of pelvic infection, four had a history of intrauterine contraceptive device use, and 10 had a prior history of Cesarean section delivery. "